ACURA PHARMACEUTICALS, INC. — Revenue by Fiscal Year
13 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/32fb3b80-94f1-4ace-93bc-2df15f80b790/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2021 | $1.6M | 2021-01-01 – 2021-12-31 | evidence 0001410578-23-001462 |
| FY 2020 | $3.6M | 2020-01-01 – 2020-12-31 | evidence 0001104659-21-044760 |
| FY 2019 | $2.7M | 2019-01-01 – 2019-12-31 | evidence 0001104659-20-040632 |
| FY 2018 | $410.0k | 2018-01-01 – 2018-12-31 | evidence 0001144204-19-044723 |
| FY 2017 | $3.0M | 2017-01-01 – 2017-12-31 | evidence 0001144204-19-044723 |
| FY 2016 | $4.5M | 2016-01-01 – 2016-12-31 | evidence 0001144204-17-018146 |
| FY 2015 | $8.6M | 2015-01-01 – 2015-12-31 | evidence 0001144204-16-085018 |
| FY 2014 | $247.0k | 2014-01-01 – 2014-12-31 | evidence 0001144204-15-013292 |
| FY 2013 | $113.0k | 2013-01-01 – 2013-12-31 | evidence 0001144204-14-012919 |
| FY 2012 | $0 | 2012-01-01 – 2012-12-31 | evidence 0001144204-14-012919 |
| FY 2011 | $0 | 2011-01-01 – 2011-12-31 | evidence 0001144204-14-012919 |
| FY 2010 | $3.3M | 2010-01-01 – 2010-12-31 | evidence 0001144204-12-012928 |
| FY 2009 | $3.8M | 2009-01-01 – 2009-12-31 | evidence 0001144204-12-012928 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ACURA PHARMACEUTICALS, INC. — all facts · Net Income · Operating Income